Orchestra BioMed (OBIO) News
NASDAQ: OBIOHealth Care Medicinal Chemicals and Botanical Products USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
OBIO news summary
We found 10 recent headlines mentioning Orchestra BioMed (OBIO): 1 in the past week and 7 in the past 30 days, most often from GlobeNewswire, Nasdaq. OBIO is making an outsized move today, down 6.00% at $6.58, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare Conference", was published by GlobeNewswire on Nov 17, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Orchestra BioMed headlines
- Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare ConferenceOrchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare ConferenceGlobeNewswire
- Orchestra BioMed Reports Third Quarter 2026 Financial Results and Highlights Recent Business UpdatesOrchestra BioMed Reports Third Quarter 2026 Financial Results and Highlights Recent Business UpdatesGlobeNewswire
- Orchestra BioMed Holdings, Inc. Closes $86.3 Million Public Offering of Common StockOn November 5, 2026, Orchestra BioMed Holdings, Inc. entered into an underwriting agreement with Piper Sandler & Co. and TD Securities (USA) LLC, as representatives of the underwriters, relating to…Nasdaq
- Orchestra BioMed Prices $75 Mln Offering At $5/Shr To Fund Pivotal Trials(RTTNews) - Orchestra BioMed Holdings, Inc. (OBIO) on Thursday priced a public offering of 15 million common shares at a price of $5 each.NasdaqMDT, OBIO, LEN.B
- Orchestra BioMed Announces Pricing of Public OfferingOrchestra BioMed Announces Pricing of Public OfferingGlobeNewswire
- Guardant Health (GH) Reports Q3 Loss, Tops Revenue EstimatesGuardant Health (GH) delivered earnings and revenue surprises of 0.00% and +2.89%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?NasdaqGH, OBIO
- Orchestra BioMed Announces Virtue SAB Presentation at TCT 2026Orchestra BioMed Announces Virtue SAB Presentation at TCT 2026GlobeNewswire
- Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SABOrchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SABGlobeNewswire
- Biotech Stocks At 52-Week Highs - TXG, OBIO, AVAH, OSCR, LFST, TVTX(RTTNews) - The biotech stocks listed below reached a new 52-week high on September 11, 2026, owing to upcoming clinical readouts and positive financial results. 10x Genomics Inc. (TXG) 10x Genomics…NasdaqAVAH, LFST, OBIO, OSCR
- Biotech Stocks At 52-Week Highs - OBIO, AVAH, TVTX, TXG, LFST(RTTNews) - The following biotech stocks reached a 52-week high on September 10, 2026, driven by significant clinical developments or financial progress. Orchestra BioMed Holdings Inc. (OBIO)…NasdaqAVAH, LFST, OBIO, TVTX